放射性核素标记溶瘤腺病毒治疗肿瘤的可行性

The Feasibility of Oncolytic Adenovirus Labeled with Radionuclides for Treating Tumors

  • 摘要: 目前,溶瘤腺病毒治疗肿瘤的研究发展非常迅速,虽然有些溶瘤腺病毒进入临床试验阶段,并取得一定疗效,但有效性和安全性仍一直是临床医生所担心的问题,本文就此简要综述了溶瘤腺病毒的研究现状及如何更有效提高溶瘤腺病毒的杀伤作用,提出了用放射性核素标记溶瘤腺病毒,以期达到溶瘤治疗和核素治疗相结合,双重杀伤肿瘤细胞的新观点。

     

    Abstract: At present, the progress of oncolytic adenoviruses in tumor therapy is very fast. Although some adenoviruses have been used in clinical trials and surely bring about therapeutic effect, killing efficiency and safety have always been worried. In this review, we summarize recent developments of oncolytic adenoviruses killing tumor cells, discuss how to enhance killing efficiency of oncolytic adenoviruses, and propose a new idea that oncolytic adenoviruses can be labeled with radionuclides, which can combine oncolytic therapy and radiotherapy.

     

/

返回文章
返回